{"id":42424,"date":"2022-03-17T11:30:24","date_gmt":"2022-03-17T11:30:24","guid":{"rendered":"https:\/\/elpais.com\/ciencia\/2022-03-17\/el-csic-defiende-su-vacuna-contra-la-covid-aunque-renuncia-a-probarla-en-humanos.html"},"modified":"2022-03-17T11:30:24","modified_gmt":"2022-03-17T11:30:24","slug":"el-csic-defiende-su-vacuna-contra-la-covid-aunque-renuncia-a-probarla-en-humanos","status":"publish","type":"post","link":"http:\/\/forocilac.org\/en\/el-csic-defiende-su-vacuna-contra-la-covid-aunque-renuncia-a-probarla-en-humanos\/","title":{"rendered":"The CSIC defends its vaccine against covid, although it renounces testing it on humans"},"content":{"rendered":"<p>La vacuna desarrollada por Mariano Esteban y Juan Garc\u00eda Arriaza, del Centro Nacional de Biotecnolog\u00eda del Consejo Superior de Investigaciones Cient\u00edficas (CNB-CSIC), ha demostrado ser eficaz para proteger a los monos de las distintas variantes del coronavirus. Un logro que, a estas alturas de la pandemia, no les permitir\u00e1 llevar su preparado hasta los brazos de los espa\u00f1oles. El equipo del CSIC acaba de publicar sus buenos resultados cient\u00edficos, a la vez que desist\u00eda de convencer a la Agencia Espa\u00f1ola del Medicamento (AEMPS) para ensayarla con personas. Mientras tanto, la vacuna de la farmac\u00e9utica catalana Hipra prosigue con sus ensayos con 3.000 voluntarios en Espa\u00f1a, Italia y Portugal.<\/p>\n<p><a href=\"https:\/\/elpais.com\/ciencia\/2022-03-17\/el-csic-defiende-su-vacuna-contra-la-covid-aunque-renuncia-a-probarla-en-humanos.html\" >Keep reading<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>El medicamento de Mariano Esteban logra proteger del virus a macacos, pero no se ensayar\u00e1 con personas porque la mayor\u00eda de los espa\u00f1oles ya est\u00e1n inmunizados<\/p>","protected":false},"author":46,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[123],"tags":[],"class_list":{"0":"post-42424","1":"post","2":"type-post","3":"status-publish","4":"format-standard","6":"category-portal"},"aioseo_notices":[],"_links":{"self":[{"href":"http:\/\/forocilac.org\/en\/wp-json\/wp\/v2\/posts\/42424","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/forocilac.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/forocilac.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/forocilac.org\/en\/wp-json\/wp\/v2\/users\/46"}],"replies":[{"embeddable":true,"href":"http:\/\/forocilac.org\/en\/wp-json\/wp\/v2\/comments?post=42424"}],"version-history":[{"count":1,"href":"http:\/\/forocilac.org\/en\/wp-json\/wp\/v2\/posts\/42424\/revisions"}],"predecessor-version":[{"id":42425,"href":"http:\/\/forocilac.org\/en\/wp-json\/wp\/v2\/posts\/42424\/revisions\/42425"}],"wp:attachment":[{"href":"http:\/\/forocilac.org\/en\/wp-json\/wp\/v2\/media?parent=42424"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/forocilac.org\/en\/wp-json\/wp\/v2\/categories?post=42424"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/forocilac.org\/en\/wp-json\/wp\/v2\/tags?post=42424"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}